Fiche publication


Date publication

avril 2014

Journal

Alimentary pharmacology & therapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent


Tous les auteurs :
Delvincourt M, Lopez A, Pillet S, Bourrier A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X, Peyrin-Biroulet L, Sokol H

Résumé

Consequences of latent cytomegalovirus (CMV) infection reactivation on inflammatory bowel disease (IBD) flare, as a flare-worsening factor or simple bystander, are debated. Impact of anti-viral treatment on IBD course is poorly known.

Mots clés

Adult, Antiviral Agents, therapeutic use, Case-Control Studies, Colitis, Ulcerative, diagnosis, Cytomegalovirus, genetics, Cytomegalovirus Infections, diagnosis, DNA, Viral, analysis, Female, France, epidemiology, Humans, Immunosuppressive Agents, therapeutic use, Male, Middle Aged, Polymerase Chain Reaction, Virus Activation, Young Adult

Référence

Aliment. Pharmacol. Ther.. 2014 Apr;39(7):712-20